Prior modeling studies showed that current outbreak management strategies are unlikely to
stop outbreaks caused by type 1 wild polioviruses (WPV1) or circulating vaccine-derived …

Background Following successful eradication of wild polioviruses and planned globally-
coordinated cessation of oral poliovirus vaccine (OPV), national and global health leaders …

Abstract Background The Global Polio Eradication Initiative plans for coordinated cessation
of oral poliovirus vaccine (OPV) use, beginning with serotype 2-containing OPV (ie, OPV2 …

Despite exhaustive and fully-financed plans to manage the risks of globally coordinated
cessation of oral poliovirus vaccine (OPV) containing type 2 (OPV2) prior to 2016, as of …

Nearly 20 years after the year 2000 target for global wild poliovirus (WPV) eradication, live
polioviruses continue to circulate with all three serotypes posing challenges for the polio …

ABSTRACT Background New York State (NYS) reported a polio case (June 2022) and
outbreak of imported type 2 circulating vaccine-derived poliovirus (cVDPV2)(last positive …

Objective To examine the impact of different bivalent oral poliovirus vaccine (bOPV)
supplemental immunization activity (SIA) strategies on population immunity to serotype 1 …

Delivering inactivated poliovirus vaccine (IPV) with oral poliovirus vaccine (OPV) in
campaigns has been explored to accelerate the control of type 2 circulating vaccine-derived …

Within the past 4 years, poliomyelitis outbreaks associated with circulating vaccine-derived
polioviruses (cVDPVs) have occurred in Hispaniola (2000-01), the Philippines (2001), and …

With national and global health policymakers facing numerous complex decisions related to
achieving and maintaining polio eradication, we expanded our previously developed …